UK Government invests £100m in new COVID-19 vaccine manufacturing site
July 23, 2020Manufacturing and Production, Research and Development COVID-19, UK, Vaccine, coronavirus
The UK Government’s Department for Business, Energy & Industrial Strategy has revealed a new pledge of an additional £100 million …
Face shields did not protect people from a COVID-19 outbreak in Switzerland but masks did, according to health officials
July 23, 2020Business Services COVID, Pandemic., coronavirus, covid19, pandemic
Health officials in Switzerland are warning against wearing plastic face shields without masks after a recent outbreak at a hotel …
Research suggests COVID-19 outcomes are worse in colder months
July 23, 2020Research and Development COVID-19, coronavirus
A partnership between Chinese and European researchers has argued that the severity of COVID-19 could be worse in colder weather …
Executives at Novavax expected to get big payouts, even if their vaccine fails clinical trials
July 23, 2020Medical Communications, Sales and Marketing COVID Vaccine, Vaccine, coronavirus
Novavax, one of the leading US firms which is developing a coronavirus vaccine, is set to award executives stock options …
British pandemic strategy has been an “astonishing” failure, says cross-party parliamentary committee
July 23, 2020Business Services COVID-19, coronavirus, pandemic
There was an “astonishing” failure of the British government to plan for the economic fallout of a potential pandemic, according …
Pfizer and BioNTech’s COVID-19 vaccine shows promise in another early stage study
July 22, 2020Research and Development BioNTech, COVID-19, Pfizer, Vaccine, pharma
BioNTech and Pfizer have revealed more promising early data on their lipid nanoparticle formulated, nucleoside-modified messenger RNA vaccine candidate against …
FDA sets out guidelines on cannabis derived drugs
July 22, 2020Research and Development CBD, CBD Oil
The FDA has released their guidelines on the rules companies should follow when developing cannabis derived drugs. The guidelines cover …
AbbVie’s Rinvoq smashes Phase 3 efficacy targets in atopic dermatits
July 22, 2020Research and Development AbbVie, atopic dermatits, pharma, upadacitinib
AbbVie has lifted the curtain on data from the second Phase 3 trial investigating the efficacy of Rinvoq (upadacitinib) monotherapy …
US indicts two Chinese hackers for attempting to steal COVID-19 drug and vaccine research
July 22, 2020Research and Development COVID-19 Vaccines, coronavirus, hacking, vaccines
Two Chinese hackers have been charged in the US with hacking medical companies and stealing hundreds of millions of dollars …
Pharmafile.com’s weekly COVID-19 news round-up
July 22, 2020Research and Development COVID-19, coronavirus
The COVID-19 news this week once again focuses on vaccines, as the UK has secured early access to 90 million …
Acadia’s pimavanserin falls short at Phase 3 in major depressive disorder
July 21, 2020Manufacturing and Production, Research and Development Acadia Pharmaceuticals, major depressive disorder, phase 3, trial failure
Acadia Pharmaceuticals has lifted the lid on new Phase 3 for its therapy pimavanserin, revealing that the drug unfortunately failed …
India begins human trials of its first homegrown coronavirus vaccine
July 21, 2020Manufacturing and Production COVID, COVID-19, Vaccine, coronavirus
India has begun human trials of its first internally developed vaccine for COVID-19. The Indian Council of Medical Research have …
AstraZeneca and Oxford University’s COVID-19 vaccine generates “robust immune responses” in early interim data
July 21, 2020Manufacturing and Production, Research and Development AstraZeneca, COVID-19, Oxford University, Vaccine, coronavirus
Interim Phase 1/2 findings have been released for the COVID-19 highly anticipated vaccine candidate in development from Oxford University and …
Fujifilm to begin clinical trials testing Avigan in COVID-19 patients in Kuwait
July 21, 2020Manufacturing and Production COVID-19, Fujifilm, Japan, avigan, coronavirus
Fujifilm will begin clinical trials investigating the effectiveness of Avigan in treating coronavirus patients in Kuwait. The trials will be …
North Korea says it’s developing its own coronavirus vaccine
July 21, 2020Manufacturing and Production COVID-19, North Korea, coronavirus
North Korea has announced it is developing a vaccine against COVID-19. The announcement was made on 18 July by the …
Is Pharma doing enough on sustainability?
July 20, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing antimicrobial resistance, manufacturing, pharma, sustainability
Adoption of sustainable practices in pharmaceutical operations is ticking along, but given the environmental and health risks if this is …
Mylan launches generic version of Gilead’s remdesivir for COVID-19 patients in India
July 20, 2020Sales and Marketing COVID-19, Gilead, India, Mylan, generic, remdesivir
Mylan has launched its own generic version of Gilead’s remdesivir on the Indian market for the treatment of patients with …
Synairgen drug doubles likelihood of recovery in hospitalised COVID-19 patients, early data show
July 20, 2020Research and Development, Sales and Marketing COVID-19, Synairgen
Respiratory drug firm Synairgen has, like many, been hard at work on a treatment for patients with COVID-19; the company …
Israeli doctor tests positive for coronavirus 3 months after recovering
July 20, 2020Sales and Marketing COVID-19, coronavirus
An Israeli doctor has appeared to have contracted COVID-19 for a second time after they tested positive for the virus …
England’s test and trace system breaks GDPR data law, according to privacy group
July 20, 2020Sales and Marketing Contact tracing, GDPR, coronavirus, covid19
England’s test and trace programme broke General Data Protection Regulation (GDPR) data law according to the Open Rights Group (ORG). …
Latest content
Major funding opportunity opens for early cancer diagnostics
Androlabs receives UK authorisation for new Testavan presentation
CEPI backs African-led Bundibugyo Ebola vaccine development
Cytomos appoints life sciences executive to board
